IRONWOOD PHARMACEUTICALS INC's ticker is IRWD and the CUSIP is 46333X108. A total of 153 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q3 2017. The put-call ratio across all filers is 3.14 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $328,287 | +5.4% | 30,854 | +4.2% | 0.04% | -17.6% |
| Q1 2023 | $311,392 | -17.0% | 29,600 | -2.3% | 0.05% | +45.7% |
| Q4 2022 | $375,330 | +19.5% | 30,293 | -0.1% | 0.04% | +12.9% |
| Q3 2022 | $314,000 | -9.5% | 30,337 | +0.7% | 0.03% | -8.8% |
| Q2 2022 | $347,000 | -62.0% | 30,134 | -37.8% | 0.03% | +142.9% |
| Q2 2017 | $914,000 | – | 48,421 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 16,390,000 | $157,835,700 | 21.26% |
| AlphaCentric Advisors LLC | 292,500 | $2,816,775 | 1.60% |
| Quantedge Capital Pte Ltd | 179,900 | $1,732,437 | 0.94% |
| Intrinsic Value Partners, LLC | 50,355 | $484,919 | 0.62% |
| Brown Capital Management | 3,719,796 | $35,821,635 | 0.55% |
| ARMISTICE CAPITAL, LLC | 3,456,000 | $33,281,280 | 0.51% |
| SummerHaven Investment Management, LLC | 67,765 | $652,577 | 0.48% |
| BRAIDWELL LP | 1,348,099 | $12,982,193 | 0.41% |
| AFFINITY INVESTMENT ADVISORS, LLC | 50,733 | $488,559 | 0.32% |
| EMC Capital Management | 43,315 | $417 | 0.31% |